These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 15361730)

  • 1. Complications of human immunodeficiency virus therapy.
    Hayes EV; McGann KA
    Pediatr Infect Dis J; 2004 Sep; 23(9):873-4. PubMed ID: 15361730
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolic and hepatobiliary side effects of antiretroviral therapy (ART).
    Lugassy DM; Farmer BM; Nelson LS
    Emerg Med Clin North Am; 2010 May; 28(2):409-19, Table of Contents. PubMed ID: 20413022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse effects of antiretroviral therapy for HIV infection.
    Montessori V; Press N; Harris M; Akagi L; Montaner JS
    CMAJ; 2004 Jan; 170(2):229-38. PubMed ID: 14734438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated liver enzymes in HIV monoinfected patients on HIV therapy: what are the implications?
    Ingiliz P; Benhamou Y
    J HIV Ther; 2009 Mar; 14(1):3-7. PubMed ID: 19731558
    [No Abstract]   [Full Text] [Related]  

  • 5. A balance of risks for the treatment of the chronically HIV-infected asymptomatic individual.
    Watson C; Fisher M
    Clin Med (Lond); 2003; 3(3):212-6. PubMed ID: 12848253
    [No Abstract]   [Full Text] [Related]  

  • 6. Steatohepatitis due to antiretroviral therapy.
    Gayle F; Lee MG; Hanchard B; Mills M
    West Indian Med J; 2008 Jan; 57(1):66-9. PubMed ID: 19565942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver disease in the HIV-infected individual.
    Price JC; Thio CL
    Clin Gastroenterol Hepatol; 2010 Dec; 8(12):1002-12. PubMed ID: 20851211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical syndromes and consequences of antiretroviral-related hepatotoxicity.
    Núñez M
    Hepatology; 2010 Sep; 52(3):1143-55. PubMed ID: 20812358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of liver fibrosis on highly active antiretroviral therapy-associated hepatotoxicity in patients with HIV and hepatitis C virus coinfection.
    Aranzabal L; Casado JL; Moya J; Quereda C; Diz S; Moreno A; Moreno L; Antela A; Perez-Elias MJ; Dronda F; Marín A; Hernandez-Ranz F; Moreno A; Moreno S
    Clin Infect Dis; 2005 Feb; 40(4):588-93. PubMed ID: 15712082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Marked dyslipidemia in human immunodeficiency virus-infected children on protease inhibitor-containing antiretroviral therapy.
    Lainka E; Oezbek S; Falck M; Ndagijimana J; Niehues T
    Pediatrics; 2002 Nov; 110(5):e56. PubMed ID: 12415062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of recurring cutaneous drug reactions in patients with human immunodeficiency virus 1 infection: a series of 3 cases.
    Dolev J; Reyter I; Maurer T
    Arch Dermatol; 2004 Sep; 140(9):1051-3. PubMed ID: 15381543
    [No Abstract]   [Full Text] [Related]  

  • 12. Sex differences in antiretroviral therapy toxicity: lactic acidosis, stavudine, and women.
    Currier JS
    Clin Infect Dis; 2007 Jul; 45(2):261-2. PubMed ID: 17578789
    [No Abstract]   [Full Text] [Related]  

  • 13. Guidelines for the evaluation and management of dyslipidemia in human immunodeficiency virus (HIV)-infected adults receiving antiretroviral therapy: recommendations of the HIV Medical Association of the Infectious Disease Society of America and the Adult AIDS Clinical Trials Group.
    Dubé MP; Stein JH; Aberg JA; Fichtenbaum CJ; Gerber JG; Tashima KT; Henry WK; Currier JS; Sprecher D; Glesby MJ; ;
    Clin Infect Dis; 2003 Sep; 37(5):613-27. PubMed ID: 12942391
    [No Abstract]   [Full Text] [Related]  

  • 14. Antiretroviral drugs and liver injury.
    Soriano V; Puoti M; Garcia-Gascó P; Rockstroh JK; Benhamou Y; Barreiro P; McGovern B
    AIDS; 2008 Jan; 22(1):1-13. PubMed ID: 18090386
    [No Abstract]   [Full Text] [Related]  

  • 15. Metabolic complications associated with the use of highly active antiretroviral therapy in HIV-1-infected adults.
    Monier PL; Wilcox R
    Am J Med Sci; 2004 Jul; 328(1):48-56. PubMed ID: 15254441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-retroviral drug induced partial anterior interosseous nerve palsy: a case report.
    Unadkat J; Wollstein R
    J Plast Reconstr Aesthet Surg; 2009 Nov; 62(11):e540-1. PubMed ID: 18938121
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of highly active antiretroviral therapy on cardiovascular involvement in children with human immunodeficiency virus infection.
    Plebani A; Esposito S; Pinzani R; Fesslova V; Bojanin J; Salice P; Rossi M; Principi N
    Pediatr Infect Dis J; 2004 Jun; 23(6):559-63. PubMed ID: 15194840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Xanthomas and hyperlipidemia in a human immunodeficiency virus-infected child receivng highly active antiretroviral therapy.
    Babl FE; Regan AM; Pelton SI
    Pediatr Infect Dis J; 2002 Mar; 21(3):259-60. PubMed ID: 12005095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quiz page June 2012: kidney failure in an HIV-positive patient.
    Coelho S; Aparício SR; Manso R; Soto K
    Am J Kidney Dis; 2012 Jun; 59(6):A27-30. PubMed ID: 22613399
    [No Abstract]   [Full Text] [Related]  

  • 20. New concerns about myocardial infarction risk.
    AIDS Patient Care STDS; 2005 Apr; 19(4):274. PubMed ID: 15918235
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.